NOROXIN Side Effects

6113129-7 | Anaphylactic Shock, Angioedema, Headache, Loss Of Consciousness
on Mar 05, 2009 Female patient from ITALY , 44 years of age, was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, angioedema, headache (What is headache?), loss of consciousness. Noroxin dosage: .

6107917-0 | Hyperkalaemia, Renal Failure Chronic
Patient was taking Noroxin (View Usage). Patient had the following side effects: hyperkalaemia, renal failure chronic on Mar 03, 2009 from FRANCE Additional patient health information: Female patient , 67 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), hyperuricaemia, hypertension and. Noroxin dosage: . During the same period patient was treated with COLCHICINE (View Colchicine Review and Colchicine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), HYDROCHLOROTHIAZIDE AND RAMIPRIL (View Hydrochlorothiazide And Ramipril Review and Hydrochlorothiazide And Ramipril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ). Patient was hospitalized.

6103994-1 | International Normalised Ratio Increased, Rectal Haemorrhage
Adverse event was reported on Mar 03, 2009 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), atrial fibrillation (What is atrial fibrillation?) and. Location: FRANCE , 90 years of age, After Noroxin was administered, patient had the following side effects: international normalised ratio increased, rectal haemorrhage. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ). Patient was hospitalized.

6098937-3 | Clostridium Difficile Colitis
on Feb 23, 2009 Male patient from FRANCE , 41 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), muscle contracture, abdominal pain upper, neuralgia, depression (What is depression?), urinary incontinence (What is urinary incontinence?) and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: clostridium difficile colitis. Noroxin dosage: . During the same period patient was treated with TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ), TRIMEBUTINE MALEATE (View Trimebutine Maleate Review and Trimebutine Maleate Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ). Patient was hospitalized.


6087166-5 | Acute Psychosis, Status Epilepticus, Suicide Attempt
on Feb 12, 2009 Female patient from UNITED KINGDOM , 44 years of age, was treated with Noroxin (View Usage). Patient had the following side effects: acute psychosis, status epilepticus, suicide attempt. Noroxin dosage: .

6075694-8 | Intentional Overdose
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: intentional overdose on Feb 06, 2009 from SWITZERLAND Additional patient health information: Female patient , 19 years of age, . Noroxin dosage: . During the same period patient was treated with METOPIMAZINE (View Metopimazine Review and Metopimazine Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6072839-0 | Intentional Overdose
Adverse event was reported on Feb 06, 2009 by a Female patient taking Noroxin (View Usage) (Dosage: ) . Location: SWITZERLAND , 19 years of age, Patient experienced the following unwanted or unexpected effects: intentional overdose. During the same period patient was treated with METOPIMAZINE (View Metopimazine Review and Metopimazine Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6012659-6 | Arthritis, Blood Creatine Phosphokinase Increased, Bursitis, Escherichia Infection, Hepatitis, Injection Site Rash, Myopathy, Pyelonephritis, Tendon Disorder
on Jun 20, 2008 Female patient from FRANCE , 52 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). Patient had the following side effects: arthritis (What is arthritis?), blood creatine phosphokinase increased, bursitis (What is bursitis?), escherichia infection, hepatitis (What is hepatitis?), injection site rash, myopathy, pyelonephritis, tendon disorder. Noroxin dosage: . Patient was hospitalized and became disabled.

5917615-1 | Arthralgia, Pain In Extremity, Tendonitis
on Oct 13, 2008 Male patient from AUSTRALIA , 60 years of age, weighting 165.3 lb, was diagnosed with prostatitis and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: arthralgia, pain in extremity, tendonitis. Noroxin dosage: .

5917608-4 | Arthralgia, Pain In Extremity, Tendonitis
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, pain in extremity, tendonitis on Oct 13, 2008 from AUSTRALIA Additional patient health information: Male patient , 60 years of age, weighting 165.3 lb, was diagnosed with prostatitis and. Noroxin dosage: .

5916601-5 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Gamma-glutamyltransferase Increased, International Normalised Ratio Increased, Lethargy
Adverse event was reported on Oct 03, 2008 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract disorder, cardiac disorder, essential hypertension and. Location: AUSTRALIA , 77 years of age, Patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, gamma-glutamyltransferase increased, international normalised ratio increased, lethargy. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

5889754-5 | Dyspnoea, Eosinophilia, Rash Erythematous, Toxic Skin Eruption
on Sep 15, 2008 Female patient from FRANCE , 85 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: dyspnoea, eosinophilia, rash erythematous, toxic skin eruption. Noroxin dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), ACEPROMAZINE AND ACEPROMETAZINE AND CLORAZEPATE DIPOTASSIUM (View Acepromazine And Aceprometazine And Clorazepate Dipotassium Review and Acepromazine And Aceprometazine And Clorazepate Dipotassium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

5863104-2 | Pemphigus
on Aug 25, 2008 Female patient from FRANCE , 60 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), pemphigus (What is pemphigus?) and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigus (What is pemphigus?). Noroxin dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE (View Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride Review and Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride Label ), CROMOLYN SODIUM (View Cromolyn Sodium Review and Cromolyn Sodium Label ). Patient was hospitalized.

5859811-8 | Pemphigus
Patient was taking Noroxin (View Usage). Patient had the following side effects: pemphigus (What is pemphigus?) on Aug 19, 2008 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), pemphigus (What is pemphigus?) and. Noroxin dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE (View Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride Review and Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride Label ), CROMOLYN SODIUM (View Cromolyn Sodium Review and Cromolyn Sodium Label ). Patient was hospitalized.

5859803-9 | Abnormal Behaviour
Adverse event was reported on Aug 19, 2008 by a Male patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), hypercholesterolaemia, atrial fibrillation (What is atrial fibrillation?), epilepsy (What is epilepsy?), type 2 diabetes mellitus, prophylaxis against gastrointestinal ulcer, thrombosis prophylaxis, abnormal behaviour and. Location: FRANCE , 81 years of age, After Noroxin was administered, patient had the following side effects: abnormal behaviour. During the same period patient was treated with PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), METFORMIN (View Metformin Review and Metformin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ). Patient was hospitalized.

5846760-4 | Abdominal Pain, Blood Amylase Increased, Diarrhoea, Gastroenteritis, Lipase Increased, Pancreatitis Acute, Pyrexia
on Aug 08, 2008 Male patient from AUSTRALIA , 23 years of age, was diagnosed with gastric infection, diarrhoea, schizophrenia and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood amylase increased, diarrhoea, gastroenteritis (What is gastroenteritis?), lipase increased, pancreatitis acute, pyrexia. Noroxin dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), FLAGYL (View Flagyl Review and Flagyl Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ). Patient was hospitalized.

5845381-7 | Vascular Purpura
on Aug 12, 2008 Female patient from FRANCE , 30 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). Patient had the following side effects: vascular purpura. Noroxin dosage: . Patient was hospitalized.

5821326-0 | Dermatitis Bullous, Purpura, Skin Exfoliation
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: dermatitis bullous, purpura, skin exfoliation on Jul 18, 2008 from FRANCE Additional patient health information: Male patient , 27 years of age, was diagnosed with dysuria, chromaturia and. Noroxin dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5816485-X | Abdominal Pain, Blood Amylase Increased, Diarrhoea, Gastroenteritis, Lipase Increased, Pancreatitis Acute, Pyrexia
Adverse event was reported on Jul 10, 2008 by a Male patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with gastric infection, diarrhoea, schizophrenia and. Location: AUSTRALIA , 23 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood amylase increased, diarrhoea, gastroenteritis (What is gastroenteritis?), lipase increased, pancreatitis acute, pyrexia. During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), FLAGYL (View Flagyl Review and Flagyl Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ). Patient was hospitalized.

5815122-8 | Dissociation, Erythema, Rash Morbilliform
on Jul 10, 2008 Female patient from FRANCE , 78 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), paraesthesia, pyrexia, sjogren's syndrome (What is sjogren's syndrome?), hypertension and was treated with Noroxin (View Usage). Patient had the following side effects: dissociation, erythema, rash morbilliform. Noroxin dosage: . During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5807440-4 | Epilepsy, Hemiparesis
on Jul 09, 2008 Female patient from ITALY , 80 years of age, was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: epilepsy (What is epilepsy?), hemiparesis. Noroxin dosage: . Patient was hospitalized.

5801836-2 | Dissociation, Erythema, Rash Morbilliform
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: dissociation, erythema, rash morbilliform on Jun 23, 2008 from FRANCE Additional patient health information: Female patient , 78 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), paraesthesia, pyrexia, sjogren's syndrome (What is sjogren's syndrome?), hypertension and. Noroxin dosage: . During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5800375-2 | Arthritis, Bacterial Pyelonephritis, Blood Creatine Phosphokinase Increased, Bursitis, Hepatitis, Injection Site Rash, Myopathy, Tendon Disorder
Adverse event was reported on Jun 20, 2008 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 52 years of age, Patient had the following side effects: arthritis (What is arthritis?), bacterial pyelonephritis, blood creatine phosphokinase increased, bursitis (What is bursitis?), hepatitis (What is hepatitis?), injection site rash, myopathy, tendon disorder. Patient was hospitalized and became disabled.

5796714-1 | Blood Creatine Phosphokinase Increased, Hepatitis, Injection Site Rash, Myopathy, Tendon Disorder
on Jun 20, 2008 Female patient from FRANCE , 52 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: blood creatine phosphokinase increased, hepatitis (What is hepatitis?), injection site rash, myopathy, tendon disorder. Noroxin dosage: . Patient was hospitalized and became disabled.

5762702-4 | Febrile Infection, Neutropenia
on Jun 03, 2008 Female patient from SWITZERLAND , 40 years of age, was diagnosed with prophylaxis, acute myeloid leukaemia and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile infection, neutropenia. Noroxin dosage: . Patient was hospitalized.

5753814-X | Hepatic Failure
Patient was taking Noroxin (View Usage). Patient had the following side effects: hepatic failure on May 23, 2008 from AUSTRALIA Additional patient health information: Female patient , 73 years of age, was diagnosed with urinary tract disorder and. Noroxin dosage: .

5748418-9 | Dyskinesia, Myoclonus
Adverse event was reported on May 20, 2008 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 79 years of age, After Noroxin was administered, patient had the following side effects: dyskinesia, myoclonus. During the same period patient was treated with NEBIVOLOL HYDROCHLORIDE (View Nebivolol Hydrochloride Review and Nebivolol Hydrochloride Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CLOMIPRAMINE HYDROCHLORIDE (View Clomipramine Hydrochloride Review and Clomipramine Hydrochloride Label ). Patient was hospitalized.

5747865-9 | Pemphigus
on May 16, 2008 Female patient from FRANCE , 60 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), pemphigus (What is pemphigus?) and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigus (What is pemphigus?). Noroxin dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE (View Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride Review and Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride Label ), CROMOLYN SODIUM (View Cromolyn Sodium Review and Cromolyn Sodium Label ). Patient was hospitalized.

5725745-2 | Peritonitis Bacterial
on Apr 23, 2008 Male patient from SPAIN , 72 years of age, was diagnosed with antibiotic prophylaxis and was treated with Noroxin (View Usage). Patient had the following side effects: peritonitis bacterial. Noroxin dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5724225-8 | Peritonitis Bacterial
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: peritonitis bacterial on Apr 23, 2008 from SPAIN Additional patient health information: Male patient , 72 years of age, was diagnosed with antibiotic prophylaxis and. Noroxin dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5713638-6 | Abdominal Pain, Cytolytic Hepatitis, Hepatitis Cholestatic, Jaundice
Adverse event was reported on Apr 18, 2008 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with cystitis and. Location: FRANCE , 17 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), cytolytic hepatitis, hepatitis cholestatic, jaundice (What is jaundice?). Patient was hospitalized.

5710392-9 | Anaemia, Haematoma, International Normalised Ratio Increased, Overdose, Renal Impairment
on Apr 17, 2008 Female patient from FRANCE , 84 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), prophylaxis, dyslipidaemia, hypertension and was treated with Noroxin (View Usage). Patient had the following side effects: anaemia, haematoma, international normalised ratio increased, overdose, renal impairment. Noroxin dosage: . During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), BENSERAZIDE HYDROCHLORIDE AND LEVODOPA (View Benserazide Hydrochloride And Levodopa Review and Benserazide Hydrochloride And Levodopa Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), POLYETHYLENE GLYCOL 3350 AND POTASSIUM CHLORIDE AND SODIUM BICARBONATE (View Polyethylene Glycol 3350 And Potassium Chloride And Sodium Bicarbonate Review and Polyethylene Glycol 3350 And Potassium Chloride And Sodium Bicarbonate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

5709536-4 | International Normalised Ratio Increased, Subcutaneous Haematoma
on Apr 15, 2008 Male patient from FRANCE , 84 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), phlebitis, rheumatoid arthritis (What is rheumatoid arthritis?), insomnia and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: international normalised ratio increased, subcutaneous haematoma. Noroxin dosage: . During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ACEBUTOLOL HYDROCHLORIDE (View Acebutolol Hydrochloride Review and Acebutolol Hydrochloride Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ), ACETAMINOPHEN AND TRAMADOL HYDROCHLORIDE (View Acetaminophen And Tramadol Hydrochloride Review and Acetaminophen And Tramadol Hydrochloride Label ). Patient was hospitalized.

5699898-9 | Epilepsy
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?) on Apr 03, 2008 from FRANCE Additional patient health information: Female patient , 95 years of age, was diagnosed with escherichia urinary tract infection, arrhythmia (What is arrhythmia?), hypocalcaemia, anaemia and. Noroxin dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), CALCIUM CARBONATE AND CHOLECALCIFEROL (View Calcium Carbonate And Cholecalciferol Review and Calcium Carbonate And Cholecalciferol Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ). Patient was hospitalized.

5692028-9 | Pain In Extremity
Adverse event was reported on Mar 28, 2008 by a Male patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED KINGDOM , 79 years of age, Patient had the following side effects: pain in extremity.

5689573-9 | Pyrexia
on Mar 26, 2008 Female patient from FRANCE , 94 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: pyrexia. Noroxin dosage: . During the same period patient was treated with AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5684439-2 | Cholestasis, Cytolytic Hepatitis
on Mar 25, 2008 Female patient from FRANCE , 74 years of age, was diagnosed with glioblastoma and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis. Noroxin dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), ACETAMINOPHEN AND PROPOXYPHENE HYDROCHLORIDE (View Acetaminophen And Propoxyphene Hydrochloride Review and Acetaminophen And Propoxyphene Hydrochloride Label ), TEMOZOLOMIDE (View Temozolomide Review and Temozolomide Label ). Patient was hospitalized.

5676901-3 | Blood Creatine Phosphokinase Increased, Hepatitis, Injection Site Rash, Myopathy, Tendon Disorder
Patient was taking Noroxin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, hepatitis (What is hepatitis?), injection site rash, myopathy, tendon disorder on Sep 21, 2007 from FRANCE Additional patient health information: Female patient , 52 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Noroxin dosage: . Patient was hospitalized and became disabled.

5673721-0 | Blood Creatine Phosphokinase Increased, Hepatitis, Injection Site Rash, Myopathy, Tendon Disorder
Adverse event was reported on Sep 21, 2007 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 52 years of age, After Noroxin was administered, patient had the following side effects: blood creatine phosphokinase increased, hepatitis (What is hepatitis?), injection site rash, myopathy, tendon disorder. Patient was hospitalized and became disabled.

5616201-0 | Hypospadias
on Jan 30, 2008 Male patient from FRANCE , weighting 6.61 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: hypospadias. Noroxin dosage: . During the same period patient was treated with PROGESTERONE (View Progesterone Review and Progesterone Label ).

5608449-6 | Muscle Spasms, Myalgia
on Jan 24, 2008 Female patient from FRANCE , 45 years of age, weighting 110.2 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), venous stasis, anaemia and was treated with Noroxin (View Usage). Patient had the following side effects: muscle spasms, myalgia. Noroxin dosage: . During the same period patient was treated with DIOSMIN (View Diosmin Review and Diosmin Label ), FERROUS SULFATE AND FOLIC ACID (View Ferrous Sulfate And Folic Acid Review and Ferrous Sulfate And Folic Acid Label ).

5595865-4 | Cholestasis, Cytolytic Hepatitis
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: cholestasis, cytolytic hepatitis on Jan 11, 2008 from FRANCE Additional patient health information: Female patient , 85 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), hypertension and. Noroxin dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

5588982-6 | Rectal Haemorrhage
Adverse event was reported on Jan 19, 2006 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), cardiac valve prosthesis user, hypertension, angiopathy, anxiety (What is anxiety?) and. Location: FRANCE , 79 years of age, Patient experienced the following unwanted or unexpected effects: rectal haemorrhage. During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ), HEPARIN CALCIUM (View Heparin Calcium Review and Heparin Calcium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), NAFRONYL OXALATE (View Nafronyl Oxalate Review and Nafronyl Oxalate Label ), TRIMETAZIDINE HYDROCHLORIDE (View Trimetazidine Hydrochloride Review and Trimetazidine Hydrochloride Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5529961-4 | Abortion Induced, Spina Bifida
on Nov 22, 2007 Female patient from FRANCE , 25 years of age, was diagnosed with pyelonephritis and was treated with Noroxin (View Usage). Patient had the following side effects: abortion induced, spina bifida (What is spina bifida?). Noroxin dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

5520227-5 | Hepatocellular Damage
on Nov 14, 2007 Female patient from SWITZERLAND , 71 years of age, weighting 143.3 lb, was diagnosed with dysuria and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: hepatocellular damage. Noroxin dosage: . Patient was hospitalized.

5508368-X | Cholestasis, Cytolytic Hepatitis
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis on Nov 05, 2007 from FRANCE Additional patient health information: Female patient , 74 years of age, . Noroxin dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), ACETAMINOPHEN AND PROPOXYPHENE HYDROCHLORIDE (View Acetaminophen And Propoxyphene Hydrochloride Review and Acetaminophen And Propoxyphene Hydrochloride Label ). Patient was hospitalized.

5508351-4 | International Normalised Ratio Increased
Adverse event was reported on Nov 05, 2007 by a Male patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), dyslipidaemia, atrial fibrillation (What is atrial fibrillation?), depression (What is depression?) and. Location: FRANCE , 78 years of age, weighting 136.7 lb, Patient had the following side effects: international normalised ratio increased. During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ). Patient was hospitalized.

5498390-4 | Hepatotoxicity
on Oct 18, 2007 Male patient from SPAIN , 39 years of age, was diagnosed with antibiotic prophylaxis and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: hepatotoxicity. Noroxin dosage: . During the same period patient was treated with CEMIDON (View Cemidon Review and Cemidon Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ). Patient was hospitalized.

5492611-X | Confusional State, Disturbance In Attention, Dystonia, Motor Dysfunction, Speech Disorder
on Oct 19, 2007 Female patient from AUSTRALIA , 15 years of age, was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, disturbance in attention, dystonia (What is dystonia?), motor dysfunction, speech disorder. Noroxin dosage: . During the same period patient was treated with PROTHIADEN (View Prothiaden Review and Prothiaden Label ). Patient was hospitalized.

5492295-0 | Abdominal Pain Upper
Patient was taking Noroxin (View Usage). Patient had the following side effects: abdominal pain upper on Oct 10, 2007 from CANADA Additional patient health information: Female patient , 40 years of age, . Noroxin dosage: Unk. During the same period patient was treated with PHENAZO (View Phenazo Review and Phenazo Label ), CYCLOMEN (View Cyclomen Review and Cyclomen Label ).